Roberto Solari

High-throughput screening and structure-based approaches to hit discovery: is there a clear winner?

Harren Jhoti, Stephen Rees, Roberto Solari, 2013, Expert opinion on drug discovery.

Safety, tolerability, pharmacokinetics and pharmacodynamics of GSK2239633, a CC-chemokine receptor 4 antagonist, in healthy male subjects: results from an open-label and from a randomised study

Misba Beerahee, Roberto Solari, Jonathan Robertson, 2012, BMC Pharmacology and Toxicology.

Animal models of asthma: value, limitations and opportunities for alternative approaches.

Stephen T Holgate, Roberto Solari, Anthony M Holmes, 2011, Drug discovery today.